Search
for
Sort by
Research 361–390 of 1000+
- Endocrine control of benign prostatic hyperplasia
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Redefining hormone resistance in prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Hormonal manipulation of benign prostatic hyperplasia
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Risk factors for prostate cancer: a case‐control study in Greece
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Recent advances in treatment for Benign Prostatic Hyperplasia
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Medical management of benign prostatic hyperplasia
- Analysis of benign prostatic obstruction surgery: A long-term evaluation in a real-life context
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM
- Finasteride and prostate cancer
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Slow progress in prostate cancer
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Estudo do estroma reativo prostático após a orquiectomia bilateral e posterior inibição da atividade da aromatase pela crisina e inibição da atividade da 5-alfa-redutase pela finasterida